Jerome Alan Grant - 27 Feb 2026 Form 4 Insider Report for UNIVERSAL TECHNICAL INSTITUTE INC (UTI)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: UTI
Reported as of: 27 Feb 2026
Net transaction value: -$2,098,494
SEC form: 4
Accepted by SEC: 02 Mar 2026, 19:45:28 UTC
Prior SEC filing: 19 Dec 2025
Next SEC filing: 30 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Christopher Kevane, Attorney-in-Fact for Jerome Alan Grant

Key filing fact

Jerome Alan Grant filed Form 4 for UNIVERSAL TECHNICAL INSTITUTE INC (UTI) on 02 Mar 2026.

Key facts

This page summarizes Jerome Alan Grant's Form 4 filing for UNIVERSAL TECHNICAL INSTITUTE INC (UTI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Mar 2026, 19:45.

Change

Previous filing in this sequence was filed on 19 Dec 2025.
Current net transaction value: -$2,098,494.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001723537 Primary reporting owner

Grant Jerome Alan

Relationship: Chief Executive Officer, Director
Address: 4225 E. WINDROSE DRIVE, SUITE 200, PHOENIX
Signature: /s/ Christopher Kevane, Attorney-in-Fact for Jerome Alan Grant
Signature date: 02 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

UTI transaction

Common Stock, $0.0001 par value

Sale

Transaction value: $2,098,494
Shares: -60,040
Change %: -12%
Price: $34.95
Shares after: 430,215
Date: 27 Feb 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares were sold by the reporting person for personal tax planning purposes.

Footnote F2

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $34.41 to $35.115. The reporting person undertakes to provide the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.